NBIX Stock Summary

• With a one year PEG ratio of 1,033.54, Neurocrine Biosciences Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 95.38% of US stocks.
• With a price/earnings ratio of 468.81, Neurocrine Biosciences Inc P/E ratio is greater than that of about 98.76% of stocks in our set with positive earnings.
• The price/operating cash flow metric for Neurocrine Biosciences Inc is higher than 96.63% of stocks in our set with a positive cash flow.
• Stocks that are quantitatively similar to NBIX, based on their financial statements, market capitalization, and price volatility, are SSTI, PODD, STAA, APPF, and AAXN.
• NBIX's SEC filings can be seen here. And to visit Neurocrine Biosciences Inc's official web site, go to www.neurocrine.com.